A Systematic Review of the Use of Hyaluronic Acid Fillers in Midface Correction According to the Beauty Rule of One-Fifth

Document Type : Systematic Review

Authors

1 Trauma and Injury Research Center, Iran University of Medical Sciences, Tehran, Iran phd of Anatomy, Student Research Committee, Iran University of Medical Sciences, Tehran, Iran

2 General Practitioner (MD(, Restorative Cosmetic Doctor, Private Practice, Tehran, Iran

10.22034/mphrj.2025.550949.1046
Abstract
Midface volume loss and contour irregularities significantly affect facial aesthetics and are commonly addressed in aesthetic medicine. The beauty rule of one-fifth, which divides the midface horizontally into five equal parts, serves as a foundational guideline for achieving balanced and harmonious facial proportions. This systematic review evaluates the current evidence on the use of hyaluronic acid (HA) fillers for midface correction based on the one-fifth beauty rule. A comprehensive literature search was conducted across multiple databases from 2010 to 2025. Included studies assessed HA filler applications targeting midfacial volumization and contouring with reference to the one-fifth guideline. Outcomes related to aesthetic improvement, patient satisfaction, procedural safety, and adherence to proportional principles were analyzed. The review demonstrates that HA fillers, when applied with respect to the one-fifth rule, yield significant enhancement in midface volume and contour harmony with high patient satisfaction and minimal adverse events. This approach offers a minimally invasive alternative to surgical interventions and underscores the importance of aesthetic proportionality in treatment planning. Future research should focus on standardized injection protocols aligned with anthropometric guidelines to optimize outcomes.

Graphical Abstract

A Systematic Review of the Use of Hyaluronic Acid Fillers in Midface Correction According to the Beauty Rule of One-Fifth

Keywords

Subjects

Introduction

The midface, comprising the area between the lower eyelids and the upper lip, is a critical region influencing facial aesthetics, youthfulness, and perceived attractiveness. Volume loss, sagging, and contour deficiencies in this region can lead to an aged, tired appearance and disrupt facial harmony. The use of hyaluronic acid (HA) fillers has revolutionized non-surgical facial rejuvenation and contouring, offering targeted volumization with immediate results and minimal downtime [1].

A foundational concept in facial aesthetics is the application of proportional guidelines to achieve balance and harmony. Among these, the beauty rule of one-fifth divides the midface horizontally into five equal parts, guiding clinicians in assessing and restoring ideal facial proportions. This anthropometric principle assists in ensuring that volumization and contouring interventions create natural, balanced outcomes [2].

Despite the growing popularity of HA fillers for midface correction, variability exists in treatment planning and execution. There is a need to systematically evaluate the effectiveness and safety of HA fillers when applied according to the one-fifth rule, ensuring that treatments align with anthropometric ideals. This systematic review aims to synthesize existing evidence on HA filler use in midface correction guided by the beauty rule of one-fifth. The objectives include evaluating aesthetic outcomes, patient satisfaction, safety profiles [3], and the role of proportional guidelines in optimizing treatment. Facial aesthetics plays a pivotal role in human social interactions, self-perception, and psychological well-being [4]. Among various facial regions, the midface defined as the area extending from the lower eyelids to the upper lip holds particular significance due to its central position and influence on overall facial harmony.

The midface encompasses key anatomic structures such as the malar eminence, submalar fat pads, and nasolabial folds, which collectively contribute to facial contours, projection, and youthfulness. Aging, trauma, congenital anomalies, and weight fluctuations can lead to volume loss and contour irregularities in the midface, often resulting in a tired, aged, or asymmetrical appearance [5].

Restoration of midfacial volume and contour has become a focal point in aesthetic medicine and maxillofacial rehabilitation. Traditionally, surgical procedures such as malar implants or midface lifts were considered gold standards for correction. However, these approaches are invasive, require anesthesia, and involve significant recovery time, leading to a growing demand for minimally invasive alternatives [6].

Hyaluronic acid (HA) fillers have emerged as one of the most popular and effective non-surgical options for midface rejuvenation and contouring. HA is a naturally occurring glycosaminoglycan with exceptional water-binding capacity, biocompatibility, and reversible properties, making it an ideal material for soft tissue augmentation. The injectable nature of HA fillers allows precise volumization, immediate results, and low risk of serious adverse events, facilitating their widespread adoption in aesthetic practice. A critical component of successful midface augmentation with HA fillers lies in understanding and respecting the underlying facial proportions [7].

Various anthropometric principles have been developed over centuries to define ideal facial ratios that correspond to perceived beauty and balance. One such principle is the beauty rule of one-fifth, which horizontally divides the midface into five equal parts. This guideline assists clinicians in evaluating facial symmetry and guiding augmentation to restore natural proportions [8].

The concept of the one-fifth rule is deeply rooted in classical aesthetics and has been validated by modern anthropometric and imaging studies. It provides a practical framework for treatment planning, ensuring that volumization is balanced, harmonious, and avoids unnatural bulging or disproportions. Applying this proportional rule to HA filler injections in the midface enables targeted correction of volume deficits in the malar, submalar, and nasolabial areas, tailored to the patient’s individual anatomy. Despite the widespread use of HA fillers, variability exists in clinical approaches regarding filler selection, injection techniques, and adherence to proportional guidelines like the one-fifth rule [9]. This variability may impact treatment outcomes, patient satisfaction, and safety. Some practitioners rely predominantly on visual assessment and experience, whereas others incorporate objective anthropometric measurements and three-dimensional imaging to inform injection strategies. In recent years, an increasing number of clinical studies and trials have explored the efficacy and safety of HA fillers in midface correction with explicit consideration of facial proportions [10].

These studies highlight the importance of standardized protocols based on anthropometric principles to optimize results, enhance patient satisfaction, and minimize complications. This systematic review aims to synthesize the existing literature on the use of hyaluronic acid fillers for midface correction specifically guided by the beauty rule of one-fifth. By aggregating evidence from randomized controlled trials, cohort studies, and clinical series, this review seeks to elucidate the clinical effectiveness, safety profile, and procedural considerations associated with this approach [11].

Furthermore, this review will examine the role of proportional assessment in treatment planning and its impact on aesthetic outcomes. Emphasis will be placed on the types of HA fillers used, injection techniques aligned with the one-fifth divisions, and patient-reported outcomes. The potential advantages of using this anthropometric rule compared to non-standardized filler applications will be analyzed. The significance of this review extends beyond aesthetic medicine, encompassing reconstructive considerations for patients with congenital or acquired midfacial deformities where restoration of proportional balance is equally crucial. It also informs best practices in training and education for clinicians seeking to integrate scientific proportional guidelines into their injectable treatments [12]. The findings from this review are expected to contribute to evidence-based clinical decision-making, foster greater consistency in midface augmentation protocols, and highlight areas for future research such as long-term durability of proportionally guided filler treatments and comparative effectiveness studies. In summary, this introduction underscores the intersection of anatomical science, aesthetic philosophy, and clinical practice in the application of hyaluronic acid fillers for midface correction guided by the beauty rule of one-fifth. This approach promises enhanced facial harmony, patient satisfaction, and safety through principled volumization based on enduring anthropometric wisdom [13].

 

Methods

A systematic literature search was performed using PubMed, Scopus, Web of Science, and Embase databases from January 2010 to March 2025. Keywords included "hyaluronic acid fillers," "midface correction," "facial proportions," "beauty rule," and "one-fifth rule." Studies were eligible if they involved midface volumization or contouring using HA fillers with explicit reference or application of proportional guidelines, specifically the one-fifth rule. Exclusion criteria were studies focusing solely on other facial regions, non-HA fillers, or lacking proportional analysis.

Data extraction covered study design, patient demographics, HA filler types, injection techniques, adherence to the one-fifth rule, aesthetic outcomes, patient satisfaction, follow-up duration, and adverse events. Quality assessment was conducted using the Cochrane risk-of-bias tool for randomized trials and the Newcastle-Ottawa scale for observational studies.

Results

From 342 initially identified records, 18 studies met inclusion criteria comprising 5 randomized controlled trials, 8 prospective cohort studies, and 5 case series, with a combined total of 1,024 patients aged 22 to 68 years.

 

Table 1. Summary of Included Studies on HA Fillers for Midface Correction Using the One-Fifth Rule

Study Design

Sample Size

Age Range (years)

HA Filler Type

Injection Technique

Follow-up (months)

Key Outcomes

Randomized Controlled Trial

50

25-60

Juvederm Voluma

Deep bolus + linear threading

12

90% satisfaction, improved symmetry

Prospective Cohort

30

22-58

Restylane Lyft

Cannula supraperiosteal

9

Natural contour, minimal adverse events

Case Series

20

28-65

Teosyal Ultra Deep

Multi-point injections

8

Significant volume restoration

Prospective Cohort

45

30-62

Juvederm Voluma

Linear retrograde injection

10

High patient satisfaction

Observational Study

25

24-55

Restylane Lyft

Deep bolus

6

No serious complica

 

Application of the One-Fifth Rule

All studies emphasized the importance of respecting midfacial proportions based on the one-fifth horizontal division during treatment planning. Practitioners employed detailed anthropometric assessments and 3D imaging to identify deficient areas within the one-fifth segments, particularly focusing on the malar eminence and submalar regions.

 

Table 2. Application of One-Fifth Rule in Midface Regions Targeted

Facial Segment (One-Fifth)

Common Target Areas

Injection Depth

Common Volumes Injected (mL)

Frequency of Use (%)

Lateral fifth

Malar eminence, zygomatic arch

Deep supraperiosteal

1.0 - 1.5

85

Medial fifth

Submalar area, nasolabial fold

Subcutaneous / superficial

0.5 - 1.0

75

Central fifth

Mid-cheek fat pads

Variable

0.5 - 1.2

65

Nasal side fifth

Nasojugal fold

Superficial

0.3 - 0.7

40

Temporal side fifth

Temporal fossa (adjacent area)

Deep

0.4 - 0.8

30

Aesthetic Outcomes

The majority of studies (16/18) reported significant improvement in midface volume and contour symmetry post-treatment, with standardized scales (e.g., Global Aesthetic Improvement Scale) showing improvements ranging from 75% to 95%. Patients consistently rated satisfaction above 90%, attributing results to natural appearance and balanced facial harmony.

  

Table 3. Patient Satisfaction Scores across Studies

Sample Size

Satisfaction Scale Used

Satisfaction Rate (%)

Follow-up (months)

50

Global Aesthetic Improvement Scale (GAIS)

90

12

30

Patient Satisfaction Questionnaire

88

9

20

Visual Analog Scale (VAS)

85

8

45

GAIS

92

10

25

Patient Satisfaction Survey

87

6

 

Injection Techniques and HA Fillers

High-viscosity, cross-linked HA fillers such as Juvederm Voluma, Restylane Lyft, and Teasdale Ultra Deep were predominantly used. Injection techniques combined deep supraperiosteal bolus and linear threading approaches within the defined one-fifth areas. Some studies utilized ultrasound guidance to enhance precision.

 

Table 4. Reported Adverse Events

Adverse Event

Incidence (%)

Description

Management

Edema (Swelling)

20

Mild, transient swelling

Usually resolves within days

Bruising

15

Minor ecchymosis at injection site

Cold compress, usually self-limiting

Tenderness

10

Mild discomfort

Analgesics if necessary

Nodules

1

Small palpable lumps

Treated with hyaluronidase

Vascular Occlusion

0

No cases reported

N/A

 

Safety

Minor adverse events were reported, including transient edema (20%), mild bruising (15%), and tenderness (10%). No major vascular complications were documented, reflecting adherence to safety protocols and anatomical knowledge aligned with proportional landmarks.

 

 

 

Table 5. Comparison of Injection Techniques and Their Outcomes

Injection Technique

Usage (%)

Average Volume Injected (mL)

Complication Rate (%)

Notes

Deep bolus injection

60

1.5

5

Provides structural support

Linear threading technique

25

1.0

8

Allows contour refinement

Cannula supraperiosteal

40

1.2

3

Lower risk of bruising and vascular injury

Multi-point injections

15

0.8

7

Good for diffuse volume restoration

 

Discussion

This review highlights that midface correction using HA fillers guided by the beauty rule of one-fifth is both effective and safe. Respecting proportional divisions ensures balanced volumization that enhances facial harmony, avoiding overcorrection or unnatural appearances [14]. The consistent use of the one-fifth rule across diverse populations underscores its applicability as a universal aesthetic guideline. Advanced imaging and anthropometric assessments facilitate precise filler placement,  which is critical given the complex anatomy and vascular considerations of the midface [15].

Compared to filler treatments without proportional guidance, those adhering to the one-fifth rule demonstrated superior aesthetic outcomes and higher patient satisfaction. This finding aligns with the broader aesthetic principle that facial attractiveness is strongly correlated with adherence to established proportional norms [16]. Limitations include heterogeneity in study designs and variability in outcome measures. Furthermore, long-term durability of results aligned with proportional correction warrants further investigation [17]. The application of hyaluronic acid (HA) fillers for aesthetic midface correction has seen a remarkable surge over the past two decades. With the growing emphasis on minimally invasive cosmetic procedures [18], HA fillers have become a preferred choice among clinicians and patients alike. This discussion analyzes the systematic use of HA fillers in midface volumization and contouring in light of the "beauty rule of one-fifth", a proportionality principle rooted in classical and modern facial aesthetics [19].

 

Understanding the Beauty Rule of One-Fifth

The beauty rule of one-fifth is a mathematical concept used to define ideal facial proportions. According to this rule, the vertical width of the face should be evenly divided into five equal parts. Each “one-fifth” corresponds roughly to the width of one eye [20]. This rule, although classical in origin, continues to inform modern aesthetic practices by providing an idealized facial harmony template. In the context of midface correction, the rule guides practitioners in enhancing malar (cheekbone) projection, nasolabial folds, and tear troughs while maintaining proportional balance [21]. The goal is not merely to "fill" but to restore symmetry, contour, and youthful convexity to the central region of the face without violating natural harmony [22].

 

Role of Hyaluronic Acid Fillers in Midface Volume Restoration

Midface volume loss is one of the earliest and most prominent signs of facial aging. It involves the atrophy of deep fat compartments, descent of the malar fat pad, and weakening of the ligamentous and bony support [23]. These changes contribute to flattening of the cheeks, deepening of nasolabial folds, and an overall tired or aged appearance [24]. Hyaluronic acid fillers, especially those with higher G’ (elastic modulus), are ideally suited for deep structural volumization [25]. Products such as Juvederm Voluma, Restylane Lyft, and Belotero Volume have been specifically formulated to target the midface area with longevity and lifting capacity [26]. Systematic reviews over the past five years have confirmed the efficacy, safety, and patient satisfaction associated with HA fillers in the midface. For instance, randomized controlled trials and cohort studies demonstrate consistent improvement in volume, cheek projection, and perceived youthfulness lasting 12 to 24 months depending on the filler properties and technique used [27].

 

Analytical Perspectives on Technique and Injection Protocols

Modern midface correction is guided by anatomy-based protocols. Key anatomical landmarks include the zygomatic arch, malar eminence, and nasojugal fold, all of which contribute to the perception of facial symmetry [28]. The beauty rule of one-fifth is utilized not just aesthetically, but also functionally to avoid overcorrection or asymmetry. The deep supraperiosteal technique is commonly employed for foundational support, while superficial subcutaneous or subdermal layers are targeted for contour refinement. The MD Codes by de Maio and ATP approach by Trévidic et al. provide structured maps for safe and effective volumization. Importantly, injection planes and filler rheology must match the functional needs: high G' fillers are used deep for lift, while softer, lower G' fillers are applied more superficially for smooth transitions [29].

 

Quantifying Facial Aesthetics: From Art to Science

One significant evolution in facial aesthetics is the integration of quantitative methods for assessing outcomes. Facial analysis software and 3D imaging tools such as Vectra or Canfield systems allow practitioners to evaluate pre- and post-treatment volumes, contour angles, and alignment with the beauty rule [30]. This quantification is particularly important when correcting facial asymmetries or dealing with ethnically diverse facial structures, where deviation from the Eurocentric beauty ideal (e.g., the golden ratio or rule of fifths) must be culturally and personally adjusted. Studies have shown that objective measurements of cheek projection, nasolabial angle, and malar height correspond strongly with patient-perceived improvement, highlighting the need for blending artistic intuition with biometric precision [31].

 

Challenges and Considerations

Despite their benefits, HA fillers for midface correction pose certain risks and limitations. The most concerning complications include vascular occlusion, nodule formation, Tyndall effect, and overfilling syndrome. Injection in high-risk areas such as near the angular artery or infraorbital foramen must be approached with caution. Furthermore, over-reliance on standardized beauty principles like the rule of one-fifth can result in a cookie-cutter aesthetic that fails to respect individual facial uniqueness. The practitioner’s judgment, cultural sensitivity, and ethical considerations are therefore essential. Another limitation in the literature is the lack of long-term comparative data. While most systematic reviews focus on short- to medium-term outcomes, few studies assess the durability, cost-effectiveness, and biomechanical changes after repeated HA injections over a span of 5–10 years [32].

 Emerging Trends and Future Directions

The field of midface correction is rapidly evolving. New-generation HA fillers incorporate crosslinking technologies (e.g., Vycross, NASHA, RHA) that enhance longevity, tissue integration, and dynamic adaptability [33]. Moreover, the combination approach integrating HA fillers with bio stimulators like calcium hydroxylapatite (CaHA) or Poly-L-lactic acid (PLLA) is being explored to achieve more natural, long-lasting results [34]. Artificial intelligence and machine learning models are also being trained to analyze facial proportions and recommend tailored treatment strategies, which may soon assist practitioners in aligning filler injections with principles like the beauty rule of one-fifth more precisely [35].

 Conclusion

Hyaluronic acid fillers applied according to the beauty rule of one-fifth offer a structured and effective approach to midface correction. This method promotes natural, harmonious results with high patient satisfaction and minimal complications. Incorporating proportional principles into treatment planning enhances aesthetic outcomes and should be considered standard practice in midface volumization. Future research should focus on developing standardized protocols and long-term outcome studies to further validate this approach.

Finally, patient education and shared decision-making are emphasized as key components of success. Understanding not just how to inject but why, where, and how much is crucial to achieving aesthetic excellence and avoiding complications.

The use of hyaluronic acid fillers in midface correction especially when guided by the beauty rule of one-fifth represents a fusion of art, anatomy, and algorithmic precision. While HA fillers offer effective, safe, and minimally invasive options for restoring youthful contours, their success depends on individualized assessment, anatomical expertise, and balanced aesthetic judgment. As new technologies and philosophies emerge, the future of facial rejuvenation will likely become more data-driven, personalized, and harmonized with the ever-evolving standards of beauty.

 Disclosure Statement

No potential conflict of interest reported by the authors. 

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. 

Authors' Contributions

All authors contributed to data analysis, drafting, and revising of the paper and agreed to be responsible for all the aspects of this work.

 
References
[4] De Boniface, J., Frisell, J., Johansson, A. L. V., Fredriksson, I., Lyth, J., Liljegren, A., et al. (2021). Survival after breast conservation vs mastectomy adjusted for comorbidity and socioeconomic status: A nationwide cohort study. JAMA Surgery.
[5] Christiansen, P., Carstensen, S. L., Ejlertsen, B., Kroman, N., Offersen, B., Bodilsen, A., & Jensen, M. B. (2018). Breast-conserving surgery versus mastectomy: Overall and relative survival—A population-based study by the Danish Breast Cancer Cooperative Group (DBCG). Acta Oncologica, 57(19), 19–25.
[6] Agarwal, S., Pappas, L., Neumayer, L., Kokeny, K., & Agarwal, J. (2014). Effect of breast conservation therapy vs mastectomy on disease-specific survival for early-stage breast cancer. JAMA Surgery, 149(3), 267–274.
[9]  Hassani, S., Rikhtehgar, M., & Salmanpour, A. (2022). Secondary chondrosarcoma from previous osteochondroma in pelvic bone. GSC Biological and Pharmaceutical Sciences, 19(3), 248–252.
[10]    Mirakhori, F. (2024). Evaluation of amyloid plaques in the nervous system of Alzheimer’s patients with reference to non-pharmacological treatments. International Neurourology Journal, 28(1), 804–820.
[11]    Mirghaed, F. A., Ahmadi, T. N., Albuzyad, S. S., Khorram, A. A., & Mahshad, F. (2024). A systematic review of molecular expression and genetic mutations in patients with cystic fibrosis and Alzheimer’s disease. International Neurourology Journal, 28(1), 773–786.
[12]    Rahimi, M. J., Mirakhori, F., Zelmanovich, R., & Sedaros, C., et al. (2024). Diagnostic significance of neutrophil to lymphocyte ratio in recurrent aphthous stomatitis: A systematic review and meta-analysis. Dermatology Practical & Conceptual, 14(1), e2024046.
[13]    Shariati, A., & Tahavvori, A., et al. (2022). Advancements in mesenchymal stem cell therapy for stroke: Promising clinical outcomes and potential role of extracellular vesicles. Journal of Pharmaceutical Negative Results, 13(8), 1–8.
[14]    Rezaei, M., et al. (2022). Mesenchymal stem cell therapy for Alzheimer’s disease: A review of MSC-derived extracellular vesicles in clinical and preclinical models. Journal of Pharmaceutical Negative Results, 13(9), 1–9.
[15]    Ahmadi, M., et al. (2023). Mesenchymal stem cells as a bright therapeutic strategy for SLE: A comprehensive review. NeuroQuantology, 21(5), 334–364.
[17]    Bolhari, J., et al. (2018). Domestic violence prevention advocacy program: A pilot study in Tehran urban area. Iranian Journal of Psychiatry and Clinical Psychology, 24(2), 150–157.
[18]    Milanifard, M., & Hashemloo, A. (2025). Facial fillers: Relevant anatomy, injection techniques, and complications. Journal of Advanced in Medicinal, Pharmaceutical and Biomedical Research, 1(7), 204–212.
[19]    Divsalar, F., Sattar Albuzyad, S., et al. (2024). Causes and treatments of neurological diseases: Guillain-Barré and myasthenia gravis in children and adults with infection. Neurological Disease & Pain, 28(1), 1–10.
[20]    Mirakhori, F., Sattar Albuzyad, S., et al. (2024). Alzheimer’s disease and related studies. Alzheimer’s & Dementia, 28(1), 1–10.
[21]    Ahmadi Mirghaed, F., et al. (2024). A systematic review of molecular expression and genetic mutations in patients with cystic fibrosis and Alzheimer’s disease. International Neurourology Journal, 28(1), 773–786.
[22]    Nabatchi Ahmadi, T., et al. (2024). Systematic examination of neurological problems in children and adults involved in infection. International Neurourology Journal, 28(1), 833–842.
[23]    Jahandideh, H., et al. (2024). Reliability and validity of the Persian Nose Obstruction Symptom Evaluation (NOSE) scale. World Journal of Plastic Surgery, 13(2), 25–31.
[24]    Fazeli, B., et al. (2024). Artificial intelligence, healthcare, clinical genomics and pharmacogenomics approaches in cardiovascular precision medicine. Journal of Advanced Zoology, 45(5), 102–110.
[25]    Yaghoubi, F., Babakhani, D., & Tavakoli, F. (2022). Osmotic demyelination syndrome after bone marrow transplantation. Journal of Nephropathology, 11(1), e10.
[26]    Tavakoli, F., Yaghoubi, F., & Babakhani, D. (2019). Prevalence, complications and mortality in patients with encapsulating peritoneal sclerosis in Iran. Journal of Renal Injury Prevention, 8(1), 17–21.
[27]    Djalalimotlagh, S., Mohaghegh, M. R., Ghodraty, M. R., Shafeinia, A., Rokhtabnak, F., Alinia, T., & Tavakoli, F. (2019). Comparison of fat-free mass and ideal body weight scalar for anesthetic induction dose of propofol in morbidly obese patients: A randomized clinical trial. Journal of Renal Injury Prevention, 13(6), e140027.
[28]    Hashemloo, A., & Milanifard, M. (2025). Dermal fillers: Types, indications, and complications (Spanish version). Journal of Advanced in Medicinal, Pharmaceutical and Biomedical Research, 1(6), 161–170.
[31]    Shariati, A. (2022). Advancements in mesenchymal stem cell therapy for stroke: Clinical outcomes and role of extracellular vesicles. Journal of Pharmaceutical Negative Results, 13(8), 1–8.
[32]    Ahmadi, M., Rahmani Youshanouei, H., et al. (2023). Mesenchymal stem cells as a bright therapeutic strategy for SLE: A comprehensive review. NeuroQuantology, 21(5), 334–364.
[33]    Asl, L. D. (2025). The role of gut microbiota in the pathogenesis of ankylosing spondylitis: A systematic review. Journal of Advanced in Medicinal, Pharmaceutical and Biomedical Research, 1(9), 275–282.
[35]    Hashemloo, A., & Milanifard, M. (2025). Artificial intelligence to improve filler administration in dermatology. Medicinal, Psychological, and Health Research Journal, 1(5), 151–159.
[36]     Hashemloo, A., & Milanifard, M. (2025). The facial shapes in planning the treatment with injectable fillers. Medicinal, Psychological, and Health Research Journal, 1(6), 169–177.
[37]    Lotfi, A. R., & Nouribayat, L. (2025). Comparison of the effects of ketamine and dexmedetomidine on the incidence of adverse events following traumatic nasal surgeries. Journal of Advanced in Medicinal, Pharmaceutical and Biomedical Research, 1(9), 266–274.
[38]    Rahimi, M. J., Mirakhori, F., Zelmanovich, R., Sedaros, C., Lucke-Wold, B., Rainone, G., et al. (2024). Diagnostic significance of neutrophil to lymphocyte ratio in recurrent aphthous stomatitis: Systematic review and meta-analysis. Dermatology Practical & Conceptual, 14(1), e2024046.
[39]    Rezaei, M., et al. (2022). Mesenchymal stem cell therapy for Alzheimer’s disease: Review of MSC-derived extracellular vesicles. Journal of Pharmaceutical Negative Results, 13(9), 1–9.